Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 28, Issue 27, 2010, Pages 4191-4198

  Drake, Matthew T ^a   Maurer, Matthew J ^a   Link, Brian K ^a   Habermann, Thomas M ^a   Ansell, Stephen M ^a   Micallef, Ivana N ^a   Kelly, Jennifer L ^a   Macon, William R ^a   Nowakowski, Grzegorz S ^a   Inwards, David J ^a   Johnston, Patrick B ^a   Singh, Ravinder J ^a   Allmer, Cristine ^a   Slager, Susan L ^a   Weiner, George J ^a   Witzig, Thomas E ^a   Cerhan, James R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; 1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; DRUG DERIVATIVE; VITAMIN D;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; COHORT ANALYSIS; ENZYME ACTIVITY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TANDEM MASS SPECTROMETRY; VITAMIN D DEFICIENCY; BLOOD; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHROMATOGRAPHY, LIQUID; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IOWA; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MINNESOTA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TANDEM MASS SPECTROMETRY; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 77957949016     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.6674     Document Type: Article

References (35)

1. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al: Hypovitaminosis D in medical inpatients. N Engl J Med 338:777-783, 1998 (Pubitemid 28135983)
2. Holick MF: High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353-373, 2006
3. Holick MF: Vitamin D deficiency. N Engl J Med 357:266-281, 2007
4. Carlberg C: Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 164:29-42, 2003
5. Bikle D: Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94:26-34, 2009
6. Gorham ED, Garland CF, Garland FC, et al: Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 97:179-194, 2005 (Pubitemid 41546228)
7. Yin L, Grandi N, Raum E, et al: Meta-analysis: Longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 30:113-125, 2009
8. Crew KD, Shane E, Cremers S, et al: High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 27:2151-2156, 2009
9. Chen P, Hu P, Xie D, et al: Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121:469-477, 2010
10. Kelly JL, Friedberg JW, Calvi LM, et al: Vitamin D and non-Hodgkin lymphoma risk in adults: A review. Cancer Invest 27:942-951, 2009
11. Kricker A, Armstrong BK, Hughes AM, et al: Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium. Int J Cancer 122:144-154, 2008 (Pubitemid 350209989)
12. Giovannucci E, Liu Y, Rimm EB, et al: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451-459, 2006
13. Lim U, Freedman DM, Hollis BW, et al: A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 124:979-986, 2009
14. Ng K, Meyerhardt JA, Wu K, et al: Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 26:2984-2991, 2008
15. Goodwin PJ, Ennis M, Pritchard KI, et al: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27:3757-3763, 2009
16. Ng AC, Kumar SK, Rajkumar SV, et al: Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma. Am J Hematol 84:397-400, 2009
17. Raina V, Cunningham D, Gilchrist N, et al: Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 63:463-465, 1991
18. Weiner GJ, Witzig TE, Link BK: The University of Iowa/Mayo Clinic Lymphoma SPORE: SPORE update. Clin Adv Hematol Oncol 2:57-59, 2004
19. Jaffe ES, Harris NL, Stein H, et al: World Health Organization Classification of Tumours: Pathology and Genetics, Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2001
20. Habermann TM, Weller EA, Morrison VA, et al: Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24:3121-3127, 2006 (Pubitemid 46638950)
21. Binkley N, Krueger D, Gemar D, et al: Correlation among 25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 93:1804-1808, 2008
22. Kotsopoulos J, Tworoger SS, Campos H, et al: Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev 19:938-946, 2010
23. Hofmann JN, Yu K, Horst RL, et al: Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial. Cancer Epidemiol Biomarkers Prev 19:927-931, 2010
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53:457-481, 1958
25. Cox DR: Regression models and life tables (with discussion). Journal of the Royal Statistical Society B 34:187-220, 1972
26. Shipp MA, Harrington DP, Anderson JR, et al: A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993
27. Solal-Celigny P, Roy P, Colombat P, et al: Follicular lymphoma international prognostic index. Blood 104:1258-1265, 2004 (Pubitemid 39166497)
28. Hoster E, Dreyling M, Klapper W, et al: A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111:558-565, 2008
29. Eilers PH, Marx BD: Flexible smoothing with B-splines and penalties. Stat Sci 11:89-121, 1996 (Pubitemid 126706128)
30. Seymour JF, Gagel RF, Hagemeister FB, et al: Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med 121:633-640, 1994
31. Provvedini DM, Tsoukas CD, Deftos LJ, et al: 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221:1181-1183, 1983
32. Hickish T, Cunningham D, Colston K, et al: The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 68:668-672, 1993 (Pubitemid 23301265)
33. Melamed ML, Michos ED, Post W, et al: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629-1637, 2008
34. Bouillon R, Okamura WH, Norman AW: Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257, 1995
35. Heaney RP: The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 97:13-19, 2005